The purpose of this review was to identify and synthesise the existing evidence on effectiveness of interventions targeting people who inject drugs at two stages of the care cascade: linkage to care and adherence to treatment of HIV, hepatitis B/C and TB.
This report documents the process and outcome of the assessment and translation of the evidence into guidance recommendations on linkage to care and/or adherence to treatment for HCV, HIV and TB for the ECDC technical report, ‘A systematic literature review of interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs’.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 October 2022 and includes updates on avian influenza, COVID-19, dengue, Ebola, invasive meningococcal disease, West Nile Virus, MERS-CoV, monkeypox, and hepatitis.
For 2020, 29 countries in the European Union/European Economic Area (EU/EEA) reported a total of 33 148 tuberculosis (TB) cases (7.3 per 100 000 population).
In 2018, 3 233 confirmed cases of invasive meningococcal disease (IMD), including 324 deaths, were reported in 30 European Union/European Economic Area (EU/EEA) Member States.
This document provides an overview of public health guidance on testing for TB infection, TB preventive treatment and screening for TB disease, in the context of the mass influx of people arriving in European countries from Ukraine.